T
1.26
0.10 (8.62%)
Previous Close | 1.16 |
Open | 1.15 |
Volume | 38,436,423 |
Avg. Volume (3M) | 28,263,676 |
Market Cap | 1,138,140,416 |
Price / Sales | 1.32 |
Price / Book | 0.350 |
52 Weeks Range | |
Earnings Date | 9 Jan 2025 |
Profit Margin | -26.18% |
Operating Margin (TTM) | -14.69% |
Diluted EPS (TTM) | -0.270 |
Quarterly Revenue Growth (YOY) | 13.10% |
Total Debt/Equity (MRQ) | 11.15% |
Current Ratio (MRQ) | 2.47 |
Operating Cash Flow (TTM) | -50.37 M |
Levered Free Cash Flow (TTM) | -35.79 M |
Return on Assets (TTM) | -1.40% |
Return on Equity (TTM) | -5.84% |
Market Trend
Short Term | Medium Term | ||
Industry | Drug Manufacturers - Specialty & Generic (US) | Bearish | Mixed |
Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
Stock | Tilray Brands, Inc. | Bearish | Bearish |
AIStockmoo Score
0.5
Analyst Consensus | -0.5 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 2.0 |
Average | 0.50 |
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Investment Style | Small Value |
% Held by Insiders | 0.67% |
% Held by Institutions | 12.10% |
52 Weeks Range | ||
Median | 1.75 (38.89%) | |
Total | 1 Hold |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Roth MKM | 11 Oct 2024 | 1.75 (38.89%) | Hold | 1.63 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |